POLAND: REMS IN THE RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS
The 2026 recommendations for the Diagnosis and treatment of Osteoporosis in Poland have been now published in the scientific journal Rheumatology (2026 edition) “Diagnosis and treatment of osteoporosis: 2026 recommendations of the Polish Society for Rheumatology”.
Tthe authors stated that REMS (Rafdiofrequency Echographic) Technology may improve access to bone densitometry and increase the detection of osteoporosis in Poland. In view of the available evidence and the Polish healthcare context, REMS may be used in the diagnosis and monitoring of osteoporosis as an alternative to DXA in women and men aged 30–90 years.
This publication presents the official recommendations of the Polish Society for Rheumatology for the diagnosis and treatment of osteoporosis. A panel of 6 experienced rheumatologists developed the document using an evidence-informed consensus process incorporating current evidence, clinical experience and the Polish healthcare context. Unanimous agreement was reached on all recommendations. The diagnostic section outlines the diagnostic criteria for osteoporosis in different patient groups and defines, for the first time, the role of Radiofrequency Echographic Multi-Spectrometry in clinical practice. The therapeutic section provides guidance on the optimal use of anti-osteoporotic drugs, including sequential therapies and the management of specific high-risk populations. These recommendations are intended to support early diagnosis and effective management of osteoporosis in Poland.
REMS & DXA
REMS assessments: clinical settings REMS technology is recognized as useful tool in the management of osteoporosis and fracture prevention. Its portability and lack of ionizing radiation means it can be used in previously underserved populations, including pregnant...
REMS technology
REMS: capable of providing information that goes beyond anthropometric modelling alone “The manuscript entitled “Methodological clarification and analysis of demographic and anthropometric determinants in the calculation of REMS bone mineral density”, authored by...
REMS & Diabete
The Advantages of REMS Technology in Type 2 Diabetes Mellitus The study “Utility of REMS-Derived Fragility Score and Trabecular Bone Score in Evaluating Bone Health in Type 2 Diabetes Mellitus” recently published by Al Refaie and colleagues in Diagnostics Journal...